Medically reviewed by Matthew Wosnitzer, MD Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

we're really talking about a cancer that has left the prostate and spread to other parts of the body. William K. Oh, M.D. continue The most common location is the bone. William K. Oh, M.D ...

In a Maple Grove industrial strip mall unequipped with the beanbag chairs common to Silicon Valley startups, Francis Medical ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

UAMS is pioneering NanoKnife technology in Arkansas for targeted prostate cancer treatment. ARKANSAS, USA — UAMS announced ...

Even among patients with prostate cancer liver metastasis who have a poor prognosis, elevated ctDNA fraction and tumor suppressor gene loss differentiate survival.